FDA Breakthrough Therapy designation granted to zovegalisib for PIK3CA-mutant, HR+/HER2- advanced breast cancer, the Phase 3 ReDiscover-2 trial ...
A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
A UCLA-led international research collaboration has unveiled a new technology that may help scientists better understand how ...
Many cancers involve upregulation of Aurora kinase B, which helps deregulate normal cell cycling to drive tumor proliferation. The kinase should therefore be a good therapeutic target, yet no ...
Comparative efficacy of cabozantinib or lenvatinib following atezolizumab plus bevacizumzb in patients with advanced hepatocellular cancer. Development and validation of a prognostic risk score for ...
Research conducted at the National Cancer Research Centre (CNIO) has revealed an unexpected behavior observed in a protein ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its proprietary RADR ® AI platform, today announced the expansion of predictBBB.ai into ...
Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results